Analysis of HER2 and HER4 in Human Myocardium to Clarify the Cardiotoxicity of Trastuzumab (Herceptin™)

By Fuchs Ilka B.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 1, 2003-01 ,pp. : 23-28

Springer Publishing Company

Access to resources Recommend Favorite

The MicroRNA-21/PTEN Pathway Regulates the Sensitivity of HER2-Positive Gastric Cancer Cells to Trastuzumab

By Eto Kojiro   Iwatsuki Masaaki   Watanabe Masayuki   Ida Satoshi   Ishimoto Takatsugu   Iwagami Shiro   Baba Yoshifumi   Sakamoto Yasuo   Miyamoto Yuji   Yoshida Naoya   Baba Hideo  

Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. : 343-350

Springer Publishing Company

Access to resources Recommend Favorite

HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment

By Weigelt Britta  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 35-43

Springer Publishing Company

Access to resources Recommend Favorite

Spotlight on Trastuzumab in Metastatic Breast Cancer Overexpressing HER2

By McKeage K.   Perry C.M.  

American Journal of Cancer, Vol. 1, Iss. 3, 2002-03 ,pp. : 217-221

Adis International

Access to resources Recommend Favorite

Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients

By Bighin Claudia   Pronzato Paolo   Del Mastro Lucia  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 955-957

Future Medicine

Access to resources Recommend Favorite